Holen Sie sich die Stockscreener-App
3.755
0.66%
-0.025
Handel nachbörslich:
3.77
0.015
+0.40%
Schlusskurs vom Vortag:
$3.78
Offen:
$3.78
24-Stunden-Volumen:
10,857
Relative Volume:
0.27
Marktkapitalisierung:
$3.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.77M
KGV:
-0.00285
EPS:
-1316.2474
Netto-Cashflow:
$-14.37M
1W Leistung:
-3.22%
1M Leistung:
-33.19%
6M Leistung:
-35.03%
1J Leistung:
+35.27%
1-Tages-Spanne:
$3.555
$3.79
1-Wochen-Bereich:
$3.55
$4.205
52-Wochen-Spanne:
$0.0927
$15.90
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Vergleichen Sie GCTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
3.755 | 3.44M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
586.24 | 207.41B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.75 | 58.46B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.13 | 39.60B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.47 | 36.63B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.52 | 32.47B | 27.43B | 1.27B | 1.01B | 1.5829 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
How GlucoTrack Inc. stock performs in rising dollar environmentJuly 2025 Big Picture & Fast Gain Stock Tips - ulpravda.ru
Will GlucoTrack Inc. stock reach all time highs in 20252025 Trade Ideas & Fast Exit/Entry Strategy Plans - ulpravda.ru
Why GlucoTrack Inc. stock remains undervaluedTrade Risk Summary & AI Powered Buy and Sell Recommendations - ulpravda.ru
Is GlucoTrack Inc. stock positioned well for digital economyWeekly Gains Report & Growth Focused Entry Reports - ulpravda.ru
Is GlucoTrack Inc. stock supported by strong fundamentalsJuly 2025 Patterns & AI Powered Trade Plan Recommendations - ulpravda.ru
Is GlucoTrack Inc. stock supported by innovation pipelineJuly 2025 Summary & AI Powered Market Entry Strategies - ulpravda.ru
ulpravda> 2026> Will GlucoTrack Inc. stock beat EPS estimatesCEO Change & Weekly High Conviction Trade Ideas - ulpravda.ru
Risk On: Is GlucoTrack Inc stock overvalued by current metricsJuly 2025 Retail & Community Consensus Stock Picks - moha.gov.vn
Levels Update: Can GlucoTrack Inc stock maintain operating marginsPortfolio Gains Report & Real-Time Market Trend Scan - moha.gov.vn
Glucotrack reports success in first human glucose monitor trial - MSN
GlucoTrack strengthens capital position with new private placement - TipRanks
Glucotrack Signs Multiple Material Agreements - TradingView — Track All Markets
Glucotrack announces pricing of private placement - Medical Buyer
Glucotrack raises $4 million in private placement to fund operations By Investing.com - Investing.com Nigeria
GlucoTrack Issues Investor Presentation Under Regulation FD - The Globe and Mail
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - The Globe and Mail
GlucoTrack stock falls after announcing $4 million private placement By Investing.com - Investing.com Australia
GlucoTrack stock falls after announcing $4 million private placement - Investing.com India
Glucotrack raises $4 million in private placement to fund operations - Investing.com India
Diabetes tech firm lands $4M backing from single institutional investor - Stock Titan
Can GlucoTrack Inc stock weather global recession2025 Major Catalysts & Precise Swing Trade Entry Alerts - moha.gov.vn
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules With a Single Institutional Investor - 富途牛牛
GlucoTrack Inc. (GCTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
GlucoTrack (NASDAQ:GCTK) Stock Price Down 2.2% – Here’s What Happened - Defense World
Breakout Move: Can GlucoTrack Inc stock weather global recession2025 Analyst Calls & Fast Entry Momentum Trade Alerts - moha.gov.vn
Why GlucoTrack Inc. stock appeals to analysts2025 Momentum Check & Free Long-Term Investment Growth Plans - Улправда
US Stocks Recap: How GlucoTrack Inc. stock performs in rate cut cycles2025 Trading Recap & Real-Time Stock Entry Alerts - Улправда
Will GlucoTrack Inc. stock deliver better than expected guidanceInsider Buying & Real-Time Stock Entry Alerts - Улправда
Can GlucoTrack Inc. stock weather global recession2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber
Will GlucoTrack Inc. stock keep outperforming rivalsTrade Entry Report & Daily Profit Focused Stock Screening - Улправда
Aug Big Picture: How GlucoTrack Inc. stock performs in rate cut cycles2025 Support & Resistance & Momentum Based Trading Ideas - ulpravda.ru
Glucotrack Adds Neuromodulation Expert to Clinical Advisory Team - Medical Product Outsourcing
Take off with GlucoTrack Inc (GCTK): Get ready for trading - setenews.com
Stock Analysis: Can GlucoTrack Inc stock weather global recession2025 Market Trends & Weekly Market Pulse Alerts - moha.gov.vn
GlucoTrack Enters Agreement to Sell Up to $20 Million of Common Shares; Stock Jumps Pre-Bell - MarketScreener
How supply chain issues affect GlucoTrack Inc. stockMarket Weekly Review & Verified Chart Pattern Trade Signals - Newser
Why GlucoTrack Inc. stock remains on watchlistsJuly 2025 Outlook & Daily Chart Pattern Signals - Newser
GlucoTrack (GCTK) Stock Analysis Report | Financials & Insights - Benzinga
GlucoTrack (NASDAQ:GCTK) Stock Price Down 7.5% – Here’s What Happened - Defense World
Head to Head Review: biote (NASDAQ:BTMD) vs. GlucoTrack (NASDAQ:GCTK) - Defense World
GlucoTrack Inc Stock Analysis and ForecastCup and Handle Formations & Superior Capital Growth - earlytimes.in
ASHFORD HOSPITALITY TRUST, INC. (AHT) - MSN
Glucotrack Reports Q3 2025 Results and Strategic Progress - MSN
What analysts say about GlucoTrack Inc stockMid Cap Growth Trends & Market Crushing Stock Picks - earlytimes.in
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.30%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):